医科达工业园扩建工程正式启动,将大幅提升高端放疗设备产能 Elekta Industrial Park expansion project kicks off , increasing the product capability for the premium radiation therapy equipment

96日,医科达工业园扩建工程开工典礼于北京昌平隆重举行。北京市昌平区人民政府、中国医学装备协会、北京市中关村科技园昌平园等相关领导及医科达公司管理层出席典礼并发表致辞。本次医科达工业园扩建工程将强有力地支持高能直线加速器多个项目新产品研发,更好地满足中国医院及放疗中心日益增长的直线加速器设备需求,是医科达深化中国市场本土化布局的又一里程碑事件。

on September 6th, the Groundbreaking Ceremony of Elekta Industrial Park expansion project took place in Changping, Beijing. Leadership from People's Government of Changping District Beijing, China Association of Medical Equipment, Beijing Zhongguancun Science Park Changping and the Elekta executives attended and addressed the meeting. Elekta Industrial Park expansion project will provide strong support to the research and development work of several new projects of linear accelerator, which will help to better meet the continuous increased demands of linear accelerator from hospitals and cancer centers in China. It is another milestone of Elekta for deepening the localization layout of China market.

 

 

 

 

 

预计实现产能提升30%,满足各级医院需求

Product capability growth by 30%, meet the demands of hospitals of all levels.

 

2006年,医科达在北京昌平投资建立研发制造基地,在国家和各级政府坚强有力的指导下,该基地已发展成为医科达全球最大的设计研发及生产制造基地,具备完整的Elekta全系列直线加速器产品的生产能力。在提高中国本土生产、研发水平的同时,也能够打造更加契合中国用户及患者的解决方案。

In 2006, the research development and manufacturing base was firstly set up by Elekta in Changping, Beijing. It has been developed as Elekta’s largest designR&D and manufacturing base in the world, with manufacturing capability of Elekta’s entire product portfolio. It is not only to promote the manufacturing, research and development level, but also build up the solutions that better matches users and patients in China.

至今,医科达北京基地的产值已提升了约40倍,未来一年,预计扩建工程建成后又将实现产能提升30%,将在很大程度上满足国内各级医院对高端放疗器械的需求。同时,这也必将加速高质量放疗产品和服务更快、更好地服务中国用户和患者。

The output value of Elekta Beijing Base has been increased by 40 times as much as it used to be. The expansion project will enable another 30% growth of the production capability, which will better meet the demand of premium radiotherapy devices from the hospitals of all levels in China largely. Meanwhile, providing radiotherapy devices with superior quality and better, faster service for the users and patients in China will be further enhanced.

 

在中国,为中国,为全球

In China, for China and for the world

 

作为深耕中国市场41年的放疗企业,医科达在坚守呵护生命这一初衷的基础上,同样遵循并贯彻把保障人民健康放在优先发展的战略位置促进优质医疗资源扩容和区域均衡布局的国家战略指示,通过支持临床科研、培养高质量放疗人才、促进本土创新等各方面的实践,助推中国卫生健康事业的高质量发展,促进先进放疗技术和产品的高水平、同质化应用,推动高质量放疗资源的公平可及,并致力于携手业界同仁助力中国放疗行业的数字化生态建设。

 

As an enterprise in radiation therapy industry, Elekta continuously invests in China Market for over forty-one years, and is committed to focus on “taking care of life” as always, also implements the national strategic instructions of “giving strategic priority to ensuring the people’s health”,” expanding the availability of quality medical resources and ensure they are better distributed among regions”. Accelerating the high quality development of China’s sanitation & health, promoting the high level of utilization of advanced radiation therapy in all areas; striving for high quality radiation therapy resources accessible for all, by supporting clinical science research, training radiation therapy talents, enhancing the local innovation practice, and making joint efforts with industry colleagues to promote the digitalization ecological construction for China’s radiation therapy industry.

 

此外,医科达已实现全球统一的高标准质量控制体系,打造出全球供应链,其北京基地生产的直线加速器销往中国及全球120多个国家和地区,实现中国智慧服务全球,真正践行在中国,为中国,为全球的发展理念。

Moreover, global unified high quality management system has been achieved by Elekta, which builds up a global supply chain. The products manufactured by Beijing base has been shipped to over 120 countries and regions, which helps to achieve the Chinese intelligence serving the world, also to truly fulfill the development concept of in China for China and for the world.

 

医科达全球执行副总裁兼中国区总裁龚安明表示:医科达在中国已历经41年的耕耘,不仅是中国快速发展与腾飞的见证者,更成为了中国卫生健康事业的重要组成部分。此次工业园扩建工程再次印证了我们坚定深耕中国市场的决心和信心,未来我们将持续与政府、行业、合作伙伴携手共筑智慧放疗生态,共同推动健康中国2030’战略目标的实现。

 

Anming Gong, Executive Vice President Elekta & President Elekta Region China, indicates that forty-one years hard work in China, makes Elekta not only a witness of China’s rapid growth, but also becomes a crucial part of China’s healthcare industry. The expansion project of Elekta Industrial Park proves again our determination and confidence that we are committed to develop in China. We will join hands with government, industry as well as our partners in the future to build up intelligent radiation therapy ecosystem, striving to achieve the strategy of “ Health China 2030”.